Michael Zimmermann

Michael Zimmermann


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2019 in Nature
Verified
Journal Article
Closed access
PDF file
MZMichael Zimmermann
Michael Zimmermann
MZMaria Zimmermann-Kogadeeva
Maria Zimmermann-Kogadeeva
RWRebekka Wegmann
Rebekka Wegmann
AGAndrew L. Goodman
Andrew L. Goodman

1 April 2015 in The Lancet Diabetes & Endocrinology
Verified
Journal Article
Closed access
MZMichael Zimmermann
Michael Zimmermann
KBKristien Boelaert
Kristien Boelaert

1 October 2014 in Cell Host & Microbe
Verified
Journal Article
Closed access
BWBrianna B. Williams
Brianna B. Williams
ABAndrew H. Van Benschoten
Andrew H. Van Benschoten
PCPeter Cimermancic
Peter Cimermancic
MDMohamed S. Donia
Mohamed S. Donia
MZMichael Zimmermann
Michael Zimmermann
MFMichael A. Fischbach
Michael A. Fischbach

4 October 2012 in Nutrition Reviews
Verified
Journal Article
Closed access
PDF file
MZMichael Zimmermann
Michael Zimmermann
MAMaria Andersson
Maria Andersson

8 February 2019 in Science
Verified
Journal Article
Closed access
PDF file
MZMichael Zimmermann
Michael Zimmermann
MZMaria Zimmermann-Kogadeeva
Maria Zimmermann-Kogadeeva
RWRebekka Wegmann
Rebekka Wegmann
AGAndrew L. Goodman
Andrew L. Goodman
Off-target drug metabolism: Anything humans swallow is exposed to the foraging and transforming activities of the gut microbiota. This applies to therapeutic drugs as well as food components and can be a major source of interpersonal variation in drug efficacy and toxicity. Zimmermann et al. found that individual drug responses depend on the genetics of an individual's microbiota. They explored the metabolism of nucleoside drugs (which are used as antivirals and antidepressants) in mice inoculated with a variety of mutant microbiota. They then modeled the pharmacokinetics in different body compartments and identified the host and microbe contributions. In some individuals, up to 70% of drug transformation can be ascribed to microbial metabolism. Science , this issue p. eaat9931

13 October 2021 in Nature
Verified
Journal Article
Closed access
PDF file
LMLisa Maier
Lisa Maier
CGCamille V. Goemans
Camille V. Goemans
JWJakob Wirbel
Jakob Wirbel
MKMichael Kuhn
Michael Kuhn
CEClaudia Eberl
Claudia Eberl
ATAthanasios Typas
Athanasios Typas